BALTIMORE, Md.--DNA Bactofection, a novel technology for introducing genes into cells using live, attenuated invasive bacterial vectors, has been licensed to Microscience Ltd. by the University System ...
LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Microscience, the vaccines developer, pulled its £140m stock market flotation yesterday, blaming poor market demand for its shares. It announced plans to float on the Alternative Investment Market in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback